8
total announcements
GKSL.NS · 15 min delayed
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mr. Paresh Dhoti as a Non-Executive Non-Independent Director, with the process being completed recently due to technical glitches.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has clarified a deficiency observation in its financial results for the quarter ended 31-Mar-2026, stating that the date mentioned for signing of the standalone financial statements was incorrect due to a typographical error. The company has undertaken to publish the corrected financial statements on its website and assured the exchange of its continued compliance with SEBI LODR Regulations.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, regarding shares dematerialised during the quarter ended on June 30, 2026.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Acquisition of 51% of Blue Tree Clinics LLC, a polyclinic duly licensed in Dubai, United Arab Emirates. The acquisition is for expansion of existing business in new geography with a set of services other than that of provided by the company in India. The consideration shall be paid in 2 tranches, with a maximum time required of 50 days. The cost of acquisition is Rs 19,83,64,500/-.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mr. (Dr) Paresh Dhoti as Non-Executive Independent Director of the company, effective July 09, 2026. The company also announced the acquisition of a 51% stake in Blue Tree Clinics LLC, UAE, and the conduct of a postal ballot for seeking approval of the shareholders for variation in the objects of the IPO.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney and Super Speciality Limited held a shareholders meeting and submitted the proceeding and scrutinizer report for the Postal Ballot (remote e-voting) on the variation in the objects/terms of utilisation of the Initial Public Offering (IPO) proceeds. The resolution was passed with a requisite majority.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Gujarat Kidney And Super Speciality Limited
The NSE has sought clarification from Gujarat Kidney And Super Speciality Limited regarding its financial results for the quarter ended 31-Mar-2026, citing Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has not yet responded.